symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
XSNX,0.058,1.499827,7312,1249059,0,0.03348-0.325,-0.006,NovAccess Global Inc.,USD,0001039466,US67001N1072,67001N107,Other OTC,PNK,Biotechnology,https://novaccessglobal.com,"NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.","Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.",Healthcare,US,2,440 644 1027,8834 Mayfield Road,Chesterland,OH,44026,,0,https://financialmodelingprep.com/image-stock/XSNX.png,1998-09-21,False,False,True,False,False
